U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Cr.2HO4S.H4N
Molecular Weight 264.176
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 2

SHOW SMILES / InChI
Structure of AMMONIUM CHROMIC SULFATE

SMILES

[NH4+].[Cr+3].OS([O-])(=O)=O.OS([O-])(=O)=O

InChI

InChIKey=RAGLTCMTCZHYEJ-UHFFFAOYSA-M
InChI=1S/Cr.H3N.2H2O4S/c;;2*1-5(2,3)4/h;1H3;2*(H2,1,2,3,4)/q+3;;;/p-1

HIDE SMILES / InChI

Molecular Formula HO4S
Molecular Weight 97.071
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Cr
Molecular Weight 51.9961
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H4N
Molecular Weight 18.0385
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
CHROMIUM

Approved Use

Chromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Launch Date

2005
PubMed

PubMed

TitleDatePubMed
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
1994 Jun
Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity.
1996 Mar
Activation of MAPKs in human bronchial epithelial cells exposed to metals.
1998 Sep
Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate.
1999 Dec
Status of antioxidant defense system in chromium-induced Swiss mice tissues.
2004 Jul
The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+.
2005 Dec 1
Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium.
2007 Aug
Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats.
2007 Nov
The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment.
2017 Sep 21
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:06:58 GMT 2023
Edited
by admin
on Sat Dec 16 10:06:58 GMT 2023
Record UNII
UTG092091O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMMONIUM CHROMIC SULFATE
MI  
Common Name English
SULFURIC ACID, AMMONIUM CHROMIUM(3+) SALT (2:1:1)
Common Name English
AMMONIUM CHROMIUM BIS(SULFATE)
Systematic Name English
AMMONIUM CHROMIUM SULFATE ((NH4)CR(SO4)2)
Common Name English
AMMONIUM CHROMIC SULFATE [MI]
Common Name English
CHROMIUM AMMONIUM ALUM
Common Name English
Code System Code Type Description
MERCK INDEX
m1778
Created by admin on Sat Dec 16 10:06:58 GMT 2023 , Edited by admin on Sat Dec 16 10:06:58 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID90929019
Created by admin on Sat Dec 16 10:06:58 GMT 2023 , Edited by admin on Sat Dec 16 10:06:58 GMT 2023
PRIMARY
ECHA (EC/EINECS)
236-923-2
Created by admin on Sat Dec 16 10:06:58 GMT 2023 , Edited by admin on Sat Dec 16 10:06:58 GMT 2023
PRIMARY
PUBCHEM
76965860
Created by admin on Sat Dec 16 10:06:58 GMT 2023 , Edited by admin on Sat Dec 16 10:06:58 GMT 2023
PRIMARY
CAS
13548-43-1
Created by admin on Sat Dec 16 10:06:58 GMT 2023 , Edited by admin on Sat Dec 16 10:06:58 GMT 2023
PRIMARY
FDA UNII
UTG092091O
Created by admin on Sat Dec 16 10:06:58 GMT 2023 , Edited by admin on Sat Dec 16 10:06:58 GMT 2023
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS